These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29953975)

  • 41. Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.
    Xiang Q; Hong D; Liao Y; Cao Y; Liu M; Pang J; Zhou J; Wang G; Yang R; Wang M; Xiang AP
    J Cell Physiol; 2017 May; 232(5):996-1007. PubMed ID: 27579673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling.
    Zhang X; Xu C; Wang C; Pei Y; He M; Wan Z; Hou J; Wang L
    Clin Exp Metastasis; 2024 Apr; 41(2):81-90. PubMed ID: 38396262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia-inducible factor-2α promotes EMT in esophageal squamous cell carcinoma through the Notch pathway.
    Ji Z; Bao S; Li L; Wang D; Shi M; Liu X
    Adv Clin Exp Med; 2022 Jul; 31(7):795-805. PubMed ID: 35394128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells.
    Loomans HA; Arnold SA; Quast LL; Andl CD
    BMC Cancer; 2016 Nov; 16(1):873. PubMed ID: 27829391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
    Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
    Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial-mesenchymal transition.
    Hu P; Wang G; Shen M; Zhang P; Zhang J; Du J; Liu Q
    Future Oncol; 2015; 11(5):771-83. PubMed ID: 25757681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
    Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
    J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased Expression of Gremlin1 Promotes Proliferation and Epithelial Mesenchymal Transition in Gastric Cancer Cells and Correlates With Poor Prognosis of Patients With Gastric Cancer.
    Sun Z; Cai S; Liu C; Cui Y; Ji J; Jiang WG; Ye L
    Cancer Genomics Proteomics; 2020; 17(1):49-60. PubMed ID: 31882551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis.
    Zhang LN; Zhang DD; Yang L; Gu YX; Zuo QP; Wang HY; Xu J; Liu DX
    FEBS J; 2021 Mar; 288(5):1447-1456. PubMed ID: 33070450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Liao Y; Xue Y; Zhang L; Feng X; Liu W; Zhang G
    J Transl Med; 2015 Oct; 13():338. PubMed ID: 26511079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SPARC expression in tumor microenvironment induces partial epithelial-to-mesenchymal transition of esophageal adenocarcinoma cells via cooperating with TGF-β signaling.
    Ma W; Yan Y; Bai S; Zhou Y; Wang X; Feng Z; Li G; Zhou S; Zhang J; Ren J
    Cell Biol Int; 2023 Jan; 47(1):250-259. PubMed ID: 36229930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma.
    Xin Z; Song X; Jiang B; Gongsun X; Song L; Qin Q; Wang Q; Shi M; Liu X
    Thorac Cancer; 2018 Dec; 9(12):1687-1698. PubMed ID: 30267473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.
    Wang ML; Pan CM; Chiou SH; Chen WH; Chang HY; Lee OK; Hsu HS; Wu CW
    Cancer Res; 2012 Nov; 72(22):6051-64. PubMed ID: 23139208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of chemerin in squamous esophageal cancer myofibroblasts and role in recruitment of mesenchymal stromal cells.
    Kumar JD; Holmberg C; Kandola S; Steele I; Hegyi P; Tiszlavicz L; Jenkins R; Beynon RJ; Peeney D; Giger OT; Alqahtani A; Wang TC; Charvat TT; Penfold M; Dockray GJ; Varro A
    PLoS One; 2014; 9(7):e104877. PubMed ID: 25127029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-1β from M2 macrophages promotes migration and invasion of ESCC cells enhancing epithelial-mesenchymal transition and activating NF-κB signaling pathway.
    Zhou J; Zheng S; Liu T; Liu Q; Chen Y; Tan D; Ma R; Lu X
    J Cell Biochem; 2018 Aug; 119(8):7040-7052. PubMed ID: 29737564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    Int J Oncol; 2016 May; 48(5):1943-54. PubMed ID: 26984177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
    Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
    J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S; Akhtar J; Wang Z
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MCP2 activates NF-κB signaling pathway promoting the migration and invasion of ESCC cells.
    Zhou J; Zheng S; Liu T; Liu Q; Chen Y; Tan D; Ma R; Lu X
    Cell Biol Int; 2018 Mar; 42(3):365-372. PubMed ID: 29148603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.